Diamond Blackfan Anemia - Bone Density Study
Determination of Bone Mineral Density in Patients with Diamond Blackfan Anemia (DBA)
Protocol ID
Protocol Description
The purpose of this study is to examine the bone density in with Diamond Blackfan Anemia (DBA) patients using an FDA approved radiological device, DXA scan (Dual Energy X-ray Absorptiometry). The DXA scan is not routinely performed in DBA patients as part of their standard care unless clinically indicated (such as in cases of bone fracture). The objective of this study is to detect early bone loss (osteopenia), severe bone loss (osteoporosis), and develop alternative treatment strategies to prevent fractures. It is anticipated that at least 30-40 patients over the next one-year will be enrolled into this study. The initial results will be analyzed after a period of one year to determine if performing DXA scans routinely can predict and/or prevent bone loss in this group of patients.
Eligibility Criteria
Patients diagnosed with Diamond Blackfan Anemia (DBA)
Primary Investigator(s)
- Adrianna Vlachos, MD